156 related articles for article (PubMed ID: 15084863)
1. Comparative in vitro activity of levofloxacin, ofloxacin, and ciprofloxacin against ocular streptococcal isolates.
Miller D; Alfonso EC
Cornea; 2004 Apr; 23(3):289-93. PubMed ID: 15084863
[TBL] [Abstract][Full Text] [Related]
2. A comparative study of the in-vitro activity of levofloxacin against Streptococcus pneumoniae.
Reinert RR; Lütticken R; Lemperle M; Bryskier A
J Antimicrob Chemother; 1999 Jun; 43 Suppl C():5-8. PubMed ID: 10404330
[TBL] [Abstract][Full Text] [Related]
3. In-vitro bacteriostatic activity of levofloxacin and three other fluoroquinolones against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
Frémaux A; Sissia G; Geslin P
J Antimicrob Chemother; 1999 Jun; 43 Suppl C():9-14. PubMed ID: 10404331
[TBL] [Abstract][Full Text] [Related]
4. Comparative in-vitro efficacy of fluoroquinolones against Streptococcus pneumoniae recovered from bacterial keratitis as determined by E-test.
Ramakrishnan R; Ramesh S; Bharathi MJ; Amuthan M; Viswanathan S
Indian J Pathol Microbiol; 2010; 53(2):276-80. PubMed ID: 20551532
[TBL] [Abstract][Full Text] [Related]
5. Comparative antistreptococcal activity of two newer fluoroquinolones, levofloxacin and sparfloxacin.
Pfaller MA; Jones RN
Diagn Microbiol Infect Dis; 1997 Nov; 29(3):199-201. PubMed ID: 9401813
[TBL] [Abstract][Full Text] [Related]
6. An in vitro resistance study of levofloxacin, ciprofloxacin, and ofloxacin using keratitis isolates of Staphylococcus aureus and Pseudomonas aeruginosa.
Kowalski RP; Pandya AN; Karenchak LM; Romanowski EG; Husted RC; Ritterband DC; Shah MK; Gordon YJ
Ophthalmology; 2001 Oct; 108(10):1826-9. PubMed ID: 11581056
[TBL] [Abstract][Full Text] [Related]
7. In-vitro activity of levofloxacin against Streptococcus pneumoniae with various levels of penicillin resistance.
Thomson KS; Chartrand SA; Sanders CC; Block SL
J Antimicrob Chemother; 1999 Jun; 43 Suppl C():15-9. PubMed ID: 10404332
[TBL] [Abstract][Full Text] [Related]
8. In vitro antimicrobial activity of levofloxacin against Streptococcus pneumoniae.
Hu BS; Fung CP; Liu PY; Lau YJ; Shi ZY; Lin YH
Zhonghua Yi Xue Za Zhi (Taipei); 1997 Oct; 60(4):191-4. PubMed ID: 9439047
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of levofloxacin against gram-positive bacteria.
Montanari MP; Mingoia M; Marchetti F; Varaldo PE
Chemotherapy; 1999; 45(6):411-7. PubMed ID: 10567771
[TBL] [Abstract][Full Text] [Related]
10. Relative potential for selection of fluoroquinolone-resistant Streptococcus pneumoniae strains by levofloxacin: comparison with ciprofloxacin, sparfloxacin and ofloxacin.
Drugeon HB; Juvin ME; Bryskier A
J Antimicrob Chemother; 1999 Jun; 43 Suppl C():55-9. PubMed ID: 10404339
[TBL] [Abstract][Full Text] [Related]
11. In-vitro activity of levofloxacin (l-ofloxacin), ofloxacin and ciprofloxacin against clinical isolates of Streptococcus pneumoniae obtained in England and Wales.
Johnson AP; Speller DC; Warner M; Domingue G
J Antimicrob Chemother; 1996 Nov; 38(5):907-8. PubMed ID: 8961064
[No Abstract] [Full Text] [Related]
12. Comparison of the postantibiotic and postantibiotic sub-MIC effects of levofloxacin and ciprofloxacin on Staphylococcus aureus and Streptococcus pneumoniae.
Licata L; Smith CE; Goldschmidt RM; Barrett JF; Frosco M
Antimicrob Agents Chemother; 1997 May; 41(5):950-5. PubMed ID: 9145850
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of fluoroquinolones against ocular bacterial isolates in São Paulo, Brazil.
Oliveira AD; D'Azevedo PA; Francisco W
Cornea; 2007 Feb; 26(2):194-8. PubMed ID: 17251812
[TBL] [Abstract][Full Text] [Related]
14. The susceptibility of Streptococcus pneumoniae to levofloxacin and other antibiotics.
Keller N; Smollen G; Davidson Y; Barzilai A; Keren G; Rubinstein E
J Antimicrob Chemother; 1999 Jun; 43 Suppl C():1-3. PubMed ID: 10404329
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of garenoxacin in treatment of experimental endocarditis due to Staphylococcus aureus or viridans group streptococci.
Entenza JM; Vouillamoz J; Glauser MP; Moreillon P
Antimicrob Agents Chemother; 2004 Jan; 48(1):86-92. PubMed ID: 14693523
[TBL] [Abstract][Full Text] [Related]
16. The bactericidal activity of levofloxacin compared with ofloxacin, D-ofloxacin, ciprofloxacin, sparfloxacin and cefotaxime against Streptococcus pneumoniae.
George J; Morrissey I
J Antimicrob Chemother; 1997 Jun; 39(6):719-23. PubMed ID: 9222040
[TBL] [Abstract][Full Text] [Related]
17. Levofloxacin in vitro activity against bacteremic isolates of Streptococcus pneumoniae. Franklin County Pneumonia Study Group.
Plouffe JF
Diagn Microbiol Infect Dis; 1996 May; 25(1):43-5. PubMed ID: 8831044
[TBL] [Abstract][Full Text] [Related]
18. Comparative in-vitro activity of levofloxacin against isolates of bacteria from adult patients with community-acquired lower respiratory tract infections.
Casellas JM; Gilardoni M; Tome G; Goldberg M; Ivanovic S; Orduna M; Dolmann A; Ascoli M; Ariza H; Montero JM
J Antimicrob Chemother; 1999 Jun; 43 Suppl C():37-42. PubMed ID: 10404336
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of levofloxacin in the treatment of experimental endocarditis caused by viridans group streptococci.
Entenza JM; Caldelari I; Glauser MP; Moreillon P
J Antimicrob Chemother; 1999 Dec; 44(6):775-86. PubMed ID: 10590278
[TBL] [Abstract][Full Text] [Related]
20. Pharmacodynamics of levofloxacin and ciprofloxacin against Streptococcus pneumoniae.
Lister PD; Sanders CC
J Antimicrob Chemother; 1999 Jan; 43(1):79-86. PubMed ID: 10381104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
